Restructuring and other charges represent amounts incurred in connection with the elimination of redundant positions and facilities and contract termination costs within the organization in connection ...

(Reuters) -Laboratory operator Labcorp beat Wall Street estimates for third-quarter profit and revenue on Thursday as strong demand for diagnostic tests offset a hit from hurricane-led disruptions.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Here's how Labcorp, the ...

Labcorp Holdings reported robust financial results for the third quarter of 2025, with adjusted earnings per share (EPS) surpassing expectations and revenue meeting forecasts. The company recorded an ...

Labcorp Holdings Inc. LH, or Labcorp, is positioning itself for sustained growth with a series of strategic acquisitions and partnerships. With a growing emphasis on cell and gene therapy, the company ...

Labcorp delivered mixed third-quarter results, with higher sales and raised profit guidance but a lower full-year revenue forecast as it “takes action” on an underperforming unit. First, overall sales ...